This inventor holds 2 USPTO granted patents. Top assignee: The Green Cross Corporation. Active years: 1981-1983.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1981-1983
Title: Eichi Hasegawa: Innovator in Myeloperoxidase Recovery
Introduction
Eichi Hasegawa is a notable inventor based in Hirakata, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the recovery of myeloperoxidase. With a total of 2 patents to his name, Hasegawa's work has the potential to impact medical treatments significantly.
Latest Patents
Hasegawa's latest patents focus on a method for recovering myeloperoxidase and its pharmaceutical applications. The method involves separating and recovering myeloperoxidase from a supernatant liquid of an aqueous dispersion of a disintegration product of human myelogenous leukocytes. This dispersion is mixed with manganese salts and protamine sulfate. The recovered myeloperoxidase, when combined with an alkali metal halide, can be utilized as a pharmaceutical composition effective against microorganisms that are deficient or diminished in catalase synthesizing activity.
Career Highlights
Eichi Hasegawa is associated with The Green Cross Corporation, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to advancing medical science and improving treatment options for various health conditions.
Collaborations
Hasegawa collaborates with Takashi Kobayashi, contributing to the development of innovative solutions in their field. Their partnership exemplifies the importance of teamwork in driving scientific advancements.
Conclusion
Eichi Hasegawa's contributions to the recovery of myeloperoxidase highlight his role as an influential inventor in the pharmaceutical industry. His innovative methods and collaborations pave the way for future advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
